T1	Participants 243 351	who are receiving conventional care alone with those receiving conventional care plus a nursing intervention
T2	Participants 394 468	Chemotherapy clinics of two comprehensive and two community cancer centers
T3	Participants 744 848	53 patients in the experimental arm and 60 in the control arm who reported pain and fatigue at baseline.
T4	Participants 1180 1212	patients in the experimental arm
T5	Participants 1474 1506	patients undergoing chemotherapy
